English

Vaxart, Inc.

EDGAR

VXRT Current report (8-K) · filed 2026-10-19

Annual consolidated revenue for 2025: about USD 237.3M, using the latest reported figures. The previous period, 2024, was about USD 28.7M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

27.2 million USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 27185000 USD Source

Operating margin

-48.45%

2026 Q2 · %

Exact inputs and evidence

Operating Income: -13172000 USD Source
Revenue: 27185000 USD Source

Operating cash flow

2.78 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: 724000 USD Source
Operating Cash Flow: -2054000 USD Source

Free cash flow

2.74 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: 724000 USD Source
Operating Cash Flow: -2054000 USD Source
Capital Expenditure: 483000 USD Source
Capital Expenditure: 448000 USD Source

Cash and cash equivalents: 22 million USD 2024-09-30 Source
Exact value

22035000 USD
Long-term debt including current maturities: 17.7 million USD 2018-12-31 Source
Exact value

17741000 USD
Shares outstanding: 243 million shares 2026-06-30 Source
Exact value

242835358 shares

Reported share-count change

6.08% · 13.9 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

228912563 shares · 2025-06-30· Source
242835358 shares · 2026-06-30· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-19.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 2025-12-31
Operating income: 9 of 11 periods available· newest 2025-12-31
Net income: 9 of 11 periods available· newest 2025-12-31
Operating cash flow: 9 of 11 periods available· newest 2025-12-31
Capital expenditure: 9 of 11 periods available· newest 2025-12-31
Total assets: 5 of 11 periods available· newest 2025-12-31
Total liabilities: 5 of 11 periods available· newest 2025-12-31
Current assets: 5 of 11 periods available· newest 2025-12-31
Current liabilities: 5 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 4 of 11 periods available· newest 2023-12-31
Long-term debt including current maturities: 2 of 11 periods available· newest 2018-12-31
Shares outstanding: 5 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+726.7%

Prior period

USD 28.7 million

2024-01-01 – 2024-12-31
Current period

USD 237.26 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

237258000 − 28700000 = 208558000 USD

28700000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
237258000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Vaxart, Inc. · 2025-12-31 Vaxart, Inc. (edgar:72444) Year-over-year change in Revenue: 208558000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 237258000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774926008023/vxrt20251231_10k.htm#1298398 Filing: 000143774926008023 Input fundies:Revenue: 28700000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774926008023/vxrt20251231_10k.htm#1299121 Filing: 000143774926008023
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 83.28 million

Prior period

−USD 66.95 million

2024-01-01 – 2024-12-31
Current period

USD 16.33 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

16327000 − -66948000 = 83275000 USD

-66948000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
16327000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Vaxart, Inc. · 2025-12-31 Vaxart, Inc. (edgar:72444) Year-over-year change in Net income: 83275000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 16327000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774926008023/vxrt20251231_10k.htm#2486454 Filing: 000143774926008023 Input fundies:NetIncome: -66948000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774926008023/vxrt20251231_10k.htm#2487275 Filing: 000143774926008023
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 52.48 million

Prior period

−USD 44.76 million

2024-01-01 – 2024-12-31
Current period

USD 7.71 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

7714000 − -44764000 = 52478000 USD

-44764000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
7714000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Vaxart, Inc. · 2025-12-31 Vaxart, Inc. (edgar:72444) Year-over-year change in Operating cash flow: 52478000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 7714000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774926008023/vxrt20251231_10k.htm#1626480 Filing: 000143774926008023 Input fundies:OperatingCashFlow: -44764000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774926008023/vxrt20251231_10k.htm#1627288 Filing: 000143774926008023
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-73.8%

Prior period

USD 554,000

2024-01-01 – 2024-12-31
Current period

USD 145,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

145000 − 554000 = -409000 USD

554000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
145000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Vaxart, Inc. · 2025-12-31 Vaxart, Inc. (edgar:72444) Year-over-year change in Capital expenditure: -409000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 145000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774926008023/vxrt20251231_10k.htm#1630478 Filing: 000143774926008023 Input fundies:CapitalExpenditure: 554000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774926008023/vxrt20251231_10k.htm#1631234 Filing: 000143774926008023
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 237.26 million 100% of revenue
Operating costs Derived USD 219.18 million 92% of revenue
Operating income USD 18.07 million 7.6% of revenue
Tax, interest and other Derived USD 1.75 million 0.7% of revenue
Net income USD 16.33 million 6.9% of revenue

Cash

Operating cash flow USD 7.71 million 3.3% of revenue
Capital expenditure USD 145,000 0.1% of revenue
Free cash flow Derived USD 7.57 million 3.2% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2017 Operating loss: operating costs were 272% of revenue.
2018 Operating loss: operating costs were 623% of revenue.
2023 Operating loss: operating costs were 1,230% of revenue.
2024 Operating loss: operating costs were 331% of revenue.
2025 92%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2017 2017-01-01 – 2017-12-31	5839000	15854000 Derived	-10015000	-433000 Derived	-9582000	-10157000 Derived	Source 2017-01-01 – 2017-12-31: 5839000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -10015000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -9582000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -10040000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 117000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	4159000	25915000 Derived	-21756000	-3749000 Derived	-18007000	-15255000 Derived	Source 2018-01-01 – 2018-12-31: 4159000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -21756000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -18007000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -14548000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 707000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	7379000	90726000 Derived	-83347000	-882000 Derived	-82465000	-72324000 Derived	Source 2023-01-01 – 2023-12-31: 7379000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -83347000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -82465000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -70453000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 1871000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	28700000	94993000 Derived	-66293000	655000 Derived	-66948000	-45318000 Derived	Source 2024-01-01 – 2024-12-31: 28700000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -66293000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -66948000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -44764000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 554000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	237258000	219184000 Derived	18074000	1747000 Derived	16327000	7569000 Derived	Source 2025-01-01 – 2025-12-31: 237258000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: 18074000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: 16327000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: 7714000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 145000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 237.3M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-12-31	Revenue	5839000	Revenue: 5839000 Open source
20182018-12-31	Revenue	4159000	Revenue: 4159000 Open source
20232023-12-31	Revenue	7379000	Revenue: 7379000 Open source
20242024-12-31	Revenue	28700000	Revenue: 28700000 Open source
20252025-12-31	Revenue	237258000	Revenue: 237258000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

726.7% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Year over year	No prior comparable period	Revenue: 5839000 Open source
20182018-12-31	Year over year	-28.8%	Revenue: 4159000 Open source Revenue: 5839000 Open source
20232023-12-31	Year over year	No prior comparable period	Revenue: 7379000 Open source
20242024-12-31	Year over year	288.9%	Revenue: 28700000 Open source Revenue: 7379000 Open source
20252025-12-31	Year over year	726.7%	Revenue: 237258000 Open source Revenue: 28700000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 7.6% 2025

Net margin 6.9% 2025

Free cash flow margin 3.2% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Operating margin	-171.5%	Operating Income: -10015000 Open source Revenue: 5839000 Open source
20182018-12-31	Operating margin	-523.1%	Operating Income: -21756000 Open source Revenue: 4159000 Open source
20232023-12-31	Operating margin	-1,129.5%	Operating Income: -83347000 Open source Revenue: 7379000 Open source
20242024-12-31	Operating margin	-231%	Operating Income: -66293000 Open source Revenue: 28700000 Open source
20252025-12-31	Operating margin	7.6%	Operating Income: 18074000 Open source Revenue: 237258000 Open source
20172017-12-31	Net margin	-164.1%	Net Income: -9582000 Open source Revenue: 5839000 Open source
20182018-12-31	Net margin	-433%	Net Income: -18007000 Open source Revenue: 4159000 Open source
20232023-12-31	Net margin	-1,117.6%	Net Income: -82465000 Open source Revenue: 7379000 Open source
20242024-12-31	Net margin	-233.3%	Net Income: -66948000 Open source Revenue: 28700000 Open source
20252025-12-31	Net margin	6.9%	Net Income: 16327000 Open source Revenue: 237258000 Open source
20172017-12-31	Free cash flow margin	-174%	Revenue: 5839000 Open source Operating Cash Flow: -10040000 Open source Capital Expenditure: 117000 Open source
20182018-12-31	Free cash flow margin	-366.8%	Revenue: 4159000 Open source Operating Cash Flow: -14548000 Open source Capital Expenditure: 707000 Open source
20232023-12-31	Free cash flow margin	-980.1%	Revenue: 7379000 Open source Operating Cash Flow: -70453000 Open source Capital Expenditure: 1871000 Open source
20242024-12-31	Free cash flow margin	-157.9%	Revenue: 28700000 Open source Operating Cash Flow: -44764000 Open source Capital Expenditure: 554000 Open source
20252025-12-31	Free cash flow margin	3.2%	Revenue: 237258000 Open source Operating Cash Flow: 7714000 Open source Capital Expenditure: 145000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 7.7M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-12-31	Operating cash flow	-10040000	Operating Cash Flow: -10040000 Open source
20182018-12-31	Operating cash flow	-14548000	Operating Cash Flow: -14548000 Open source
20232023-12-31	Operating cash flow	-70453000	Operating Cash Flow: -70453000 Open source
20242024-12-31	Operating cash flow	-44764000	Operating Cash Flow: -44764000 Open source
20252025-12-31	Operating cash flow	7714000	Operating Cash Flow: 7714000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 7.6M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-12-31	Free cash flow	-10157000	Operating Cash Flow: -10040000 Open source Capital Expenditure: 117000 Open source
20182018-12-31	Free cash flow	-15255000	Operating Cash Flow: -14548000 Open source Capital Expenditure: 707000 Open source
20232023-12-31	Free cash flow	-72324000	Operating Cash Flow: -70453000 Open source Capital Expenditure: 1871000 Open source
20242024-12-31	Free cash flow	-45318000	Operating Cash Flow: -44764000 Open source Capital Expenditure: 554000 Open source
20252025-12-31	Free cash flow	7569000	Operating Cash Flow: 7714000 Open source Capital Expenditure: 145000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

52.8% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Liabilities / assets	956.1%	Total Liabilities: 43245000 Open source Total Assets: 4523000 Open source
20182018-12-31	Liabilities / assets	68.1%	Total Liabilities: 23989000 Open source Total Assets: 35227000 Open source
20232023-12-31	Liabilities / assets	37.1%	Total Liabilities: 34025000 Open source Total Assets: 91830000 Open source
20242024-12-31	Liabilities / assets	64.6%	Total Liabilities: 107464000 Open source Total Assets: 166389000 Open source
20252025-12-31	Liabilities / assets	52.8%	Total Liabilities: 98281000 Open source Total Assets: 186079000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.57× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Current assets / current liabilities	0.83×	Current Assets: 3753000 Open source Current Liabilities: 4523000 Open source
20182018-12-31	Current assets / current liabilities	1.96×	Current Assets: 14645000 Open source Current Liabilities: 7475000 Open source
20232023-12-31	Current assets / current liabilities	3.32×	Current Assets: 45536000 Open source Current Liabilities: 13724000 Open source
20242024-12-31	Current assets / current liabilities	0.75×	Current Assets: 68260000 Open source Current Liabilities: 90878000 Open source
20252025-12-31	Current assets / current liabilities	1.57×	Current Assets: 136123000 Open source Current Liabilities: 86754000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2017 2017-01-01 – 2017-12-31	−USD 9.58 million Exact value Exact value: -9582000 USD 2017-01-01 – 2017-12-31: -9582000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Vaxart, Inc. · 2017-12-31 Vaxart, Inc. (edgar:72444) Net Income: -9582000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9582000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000151316219000041/vxrt-20181231.xml#122563 Filing: 000151316219000041 The citation records this snapshot. The page link may show a newer release later.	−USD 10.04 million Exact value Exact value: -10040000 USD 2017-01-01 – 2017-12-31: -10040000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Vaxart, Inc. · 2017-12-31 Vaxart, Inc. (edgar:72444) Operating Cash Flow: -10040000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10040000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000151316219000041/vxrt-20181231.xml#136887 Filing: 000151316219000041 The citation records this snapshot. The page link may show a newer release later.	USD 117,000 Exact value Exact value: 117000 USD 2017-01-01 – 2017-12-31: 117000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Vaxart, Inc. · 2017-12-31 Vaxart, Inc. (edgar:72444) Capital Expenditure: 117000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 117000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000151316219000041/vxrt-20181231.xml#137254 Filing: 000151316219000041 The citation records this snapshot. The page link may show a newer release later.	−USD 10.16 million Calculation and evidence -10040000 − 117000 USD Exact free cash flow: -10157000 USD 2017-01-01 – 2017-12-31: -10040000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 117000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Vaxart, Inc. · 2017-12-31 Vaxart, Inc. (edgar:72444) Free cash flow: -10157000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10040000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000151316219000041/vxrt-20181231.xml#136887 Filing: 000151316219000041 Input fundies:CapitalExpenditure: 117000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000151316219000041/vxrt-20181231.xml#137254 Filing: 000151316219000041 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 18.01 million Exact value Exact value: -18007000 USD 2018-01-01 – 2018-12-31: -18007000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Vaxart, Inc. · 2018-12-31 Vaxart, Inc. (edgar:72444) Net Income: -18007000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18007000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000151316219000041/vxrt-20181231.xml#122436 Filing: 000151316219000041 The citation records this snapshot. The page link may show a newer release later.	−USD 14.55 million Exact value Exact value: -14548000 USD 2018-01-01 – 2018-12-31: -14548000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Vaxart, Inc. · 2018-12-31 Vaxart, Inc. (edgar:72444) Operating Cash Flow: -14548000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14548000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000151316219000041/vxrt-20181231.xml#136702 Filing: 000151316219000041 The citation records this snapshot. The page link may show a newer release later.	USD 707,000 Exact value Exact value: 707000 USD 2018-01-01 – 2018-12-31: 707000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Vaxart, Inc. · 2018-12-31 Vaxart, Inc. (edgar:72444) Capital Expenditure: 707000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 707000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000151316219000041/vxrt-20181231.xml#137072 Filing: 000151316219000041 The citation records this snapshot. The page link may show a newer release later.	−USD 15.26 million Calculation and evidence -14548000 − 707000 USD Exact free cash flow: -15255000 USD 2018-01-01 – 2018-12-31: -14548000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 707000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Vaxart, Inc. · 2018-12-31 Vaxart, Inc. (edgar:72444) Free cash flow: -15255000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -14548000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000151316219000041/vxrt-20181231.xml#136702 Filing: 000151316219000041 Input fundies:CapitalExpenditure: 707000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000151316219000041/vxrt-20181231.xml#137072 Filing: 000151316219000041 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 18.65 million Exact value Exact value: -18645000 USD 2019-01-01 – 2019-12-31: -18645000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Vaxart, Inc. · 2019-12-31 Vaxart, Inc. (edgar:72444) Net Income: -18645000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18645000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774922004354/vxrt20211231_10k.htm#2782690 Filing: 000143774922004354 The citation records this snapshot. The page link may show a newer release later.	−USD 13.09 million Exact value Exact value: -13090000 USD 2019-01-01 – 2019-12-31: -13090000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Vaxart, Inc. · 2019-12-31 Vaxart, Inc. (edgar:72444) Operating Cash Flow: -13090000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13090000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774922004354/vxrt20211231_10k.htm#1906664 Filing: 000143774922004354 The citation records this snapshot. The page link may show a newer release later.	USD 850,000 Exact value Exact value: 850000 USD 2019-01-01 – 2019-12-31: 850000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Vaxart, Inc. · 2019-12-31 Vaxart, Inc. (edgar:72444) Capital Expenditure: 850000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 850000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774922004354/vxrt20211231_10k.htm#1911227 Filing: 000143774922004354 The citation records this snapshot. The page link may show a newer release later.	−USD 13.94 million Calculation and evidence -13090000 − 850000 USD Exact free cash flow: -13940000 USD 2019-01-01 – 2019-12-31: -13090000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 850000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Vaxart, Inc. · 2019-12-31 Vaxart, Inc. (edgar:72444) Free cash flow: -13940000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13090000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774922004354/vxrt20211231_10k.htm#1906664 Filing: 000143774922004354 Input fundies:CapitalExpenditure: 850000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774922004354/vxrt20211231_10k.htm#1911227 Filing: 000143774922004354 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 32.22 million Exact value Exact value: -32220000 USD 2020-01-01 – 2020-12-31: -32220000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Vaxart, Inc. · 2020-12-31 Vaxart, Inc. (edgar:72444) Net Income: -32220000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -32220000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774922004354/vxrt20211231_10k.htm#2782009 Filing: 000143774922004354 The citation records this snapshot. The page link may show a newer release later.	−USD 23.75 million Exact value Exact value: -23750000 USD 2020-01-01 – 2020-12-31: -23750000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Vaxart, Inc. · 2020-12-31 Vaxart, Inc. (edgar:72444) Operating Cash Flow: -23750000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23750000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774922004354/vxrt20211231_10k.htm#1905840 Filing: 000143774922004354 The citation records this snapshot. The page link may show a newer release later.	USD 1.22 million Exact value Exact value: 1223000 USD 2020-01-01 – 2020-12-31: 1223000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Vaxart, Inc. · 2020-12-31 Vaxart, Inc. (edgar:72444) Capital Expenditure: 1223000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1223000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774922004354/vxrt20211231_10k.htm#1910512 Filing: 000143774922004354 The citation records this snapshot. The page link may show a newer release later.	−USD 24.97 million Calculation and evidence -23750000 − 1223000 USD Exact free cash flow: -24973000 USD 2020-01-01 – 2020-12-31: -23750000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 1223000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Vaxart, Inc. · 2020-12-31 Vaxart, Inc. (edgar:72444) Free cash flow: -24973000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -23750000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774922004354/vxrt20211231_10k.htm#1905840 Filing: 000143774922004354 Input fundies:CapitalExpenditure: 1223000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774922004354/vxrt20211231_10k.htm#1910512 Filing: 000143774922004354 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 70.47 million Exact value Exact value: -70470000 USD 2021-01-01 – 2021-12-31: -70470000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Vaxart, Inc. · 2021-12-31 Vaxart, Inc. (edgar:72444) Net Income: -70470000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -70470000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774923006688/vxrt20221231_10k.htm#2197933 Filing: 000143774923006688 The citation records this snapshot. The page link may show a newer release later.	−USD 59.83 million Exact value Exact value: -59832000 USD 2021-01-01 – 2021-12-31: -59832000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Vaxart, Inc. · 2021-12-31 Vaxart, Inc. (edgar:72444) Operating Cash Flow: -59832000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -59832000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774923006688/vxrt20221231_10k.htm#1561788 Filing: 000143774923006688 The citation records this snapshot. The page link may show a newer release later.	USD 5.16 million Exact value Exact value: 5157000 USD 2021-01-01 – 2021-12-31: 5157000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Vaxart, Inc. · 2021-12-31 Vaxart, Inc. (edgar:72444) Capital Expenditure: 5157000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5157000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774923006688/vxrt20221231_10k.htm#1564823 Filing: 000143774923006688 The citation records this snapshot. The page link may show a newer release later.	−USD 64.99 million Calculation and evidence -59832000 − 5157000 USD Exact free cash flow: -64989000 USD 2021-01-01 – 2021-12-31: -59832000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 5157000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Vaxart, Inc. · 2021-12-31 Vaxart, Inc. (edgar:72444) Free cash flow: -64989000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -59832000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774923006688/vxrt20221231_10k.htm#1561788 Filing: 000143774923006688 Input fundies:CapitalExpenditure: 5157000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774923006688/vxrt20221231_10k.htm#1564823 Filing: 000143774923006688 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 107.76 million Exact value Exact value: -107758000 USD 2022-01-01 – 2022-12-31: -107758000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Vaxart, Inc. · 2022-12-31 Vaxart, Inc. (edgar:72444) Net Income: -107758000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -107758000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774924007865/vxrt20231231_10k.htm#2047900 Filing: 000143774924007865 The citation records this snapshot. The page link may show a newer release later.	−USD 94.78 million Exact value Exact value: -94779000 USD 2022-01-01 – 2022-12-31: -94779000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Vaxart, Inc. · 2022-12-31 Vaxart, Inc. (edgar:72444) Operating Cash Flow: -94779000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -94779000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774924007865/vxrt20231231_10k.htm#1428333 Filing: 000143774924007865 The citation records this snapshot. The page link may show a newer release later.	USD 9.6 million Exact value Exact value: 9601000 USD 2022-01-01 – 2022-12-31: 9601000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Vaxart, Inc. · 2022-12-31 Vaxart, Inc. (edgar:72444) Capital Expenditure: 9601000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 9601000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774924007865/vxrt20231231_10k.htm#1431377 Filing: 000143774924007865 The citation records this snapshot. The page link may show a newer release later.	−USD 104.38 million Calculation and evidence -94779000 − 9601000 USD Exact free cash flow: -104380000 USD 2022-01-01 – 2022-12-31: -94779000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 9601000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Vaxart, Inc. · 2022-12-31 Vaxart, Inc. (edgar:72444) Free cash flow: -104380000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -94779000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774924007865/vxrt20231231_10k.htm#1428333 Filing: 000143774924007865 Input fundies:CapitalExpenditure: 9601000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774924007865/vxrt20231231_10k.htm#1431377 Filing: 000143774924007865 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 82.47 million Exact value Exact value: -82465000 USD 2023-01-01 – 2023-12-31: -82465000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Vaxart, Inc. · 2023-12-31 Vaxart, Inc. (edgar:72444) Net Income: -82465000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -82465000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774925008572/vxrt20241231_10k.htm#2245476 Filing: 000143774925008572 The citation records this snapshot. The page link may show a newer release later.	−USD 70.45 million Exact value Exact value: -70453000 USD 2023-01-01 – 2023-12-31: -70453000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Vaxart, Inc. · 2023-12-31 Vaxart, Inc. (edgar:72444) Operating Cash Flow: -70453000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -70453000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774925008572/vxrt20241231_10k.htm#1531260 Filing: 000143774925008572 The citation records this snapshot. The page link may show a newer release later.	USD 1.87 million Exact value Exact value: 1871000 USD 2023-01-01 – 2023-12-31: 1871000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Vaxart, Inc. · 2023-12-31 Vaxart, Inc. (edgar:72444) Capital Expenditure: 1871000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1871000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774925008572/vxrt20241231_10k.htm#1534399 Filing: 000143774925008572 The citation records this snapshot. The page link may show a newer release later.	−USD 72.32 million Calculation and evidence -70453000 − 1871000 USD Exact free cash flow: -72324000 USD 2023-01-01 – 2023-12-31: -70453000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 1871000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Vaxart, Inc. · 2023-12-31 Vaxart, Inc. (edgar:72444) Free cash flow: -72324000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -70453000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774925008572/vxrt20241231_10k.htm#1531260 Filing: 000143774925008572 Input fundies:CapitalExpenditure: 1871000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774925008572/vxrt20241231_10k.htm#1534399 Filing: 000143774925008572 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 66.95 million Exact value Exact value: -66948000 USD 2024-01-01 – 2024-12-31: -66948000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Vaxart, Inc. · 2024-12-31 Vaxart, Inc. (edgar:72444) Net Income: -66948000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -66948000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774926008023/vxrt20251231_10k.htm#2487275 Filing: 000143774926008023 The citation records this snapshot. The page link may show a newer release later.	−USD 44.76 million Exact value Exact value: -44764000 USD 2024-01-01 – 2024-12-31: -44764000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Vaxart, Inc. · 2024-12-31 Vaxart, Inc. (edgar:72444) Operating Cash Flow: -44764000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -44764000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774926008023/vxrt20251231_10k.htm#1627288 Filing: 000143774926008023 The citation records this snapshot. The page link may show a newer release later.	USD 554,000 Exact value Exact value: 554000 USD 2024-01-01 – 2024-12-31: 554000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Vaxart, Inc. · 2024-12-31 Vaxart, Inc. (edgar:72444) Capital Expenditure: 554000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 554000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774926008023/vxrt20251231_10k.htm#1631234 Filing: 000143774926008023 The citation records this snapshot. The page link may show a newer release later.	−USD 45.32 million Calculation and evidence -44764000 − 554000 USD Exact free cash flow: -45318000 USD 2024-01-01 – 2024-12-31: -44764000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 554000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Vaxart, Inc. · 2024-12-31 Vaxart, Inc. (edgar:72444) Free cash flow: -45318000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -44764000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774926008023/vxrt20251231_10k.htm#1627288 Filing: 000143774926008023 Input fundies:CapitalExpenditure: 554000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774926008023/vxrt20251231_10k.htm#1631234 Filing: 000143774926008023 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	USD 16.33 million Exact value Exact value: 16327000 USD 2025-01-01 – 2025-12-31: 16327000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Vaxart, Inc. · 2025-12-31 Vaxart, Inc. (edgar:72444) Net Income: 16327000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: 16327000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774926008023/vxrt20251231_10k.htm#2486454 Filing: 000143774926008023 The citation records this snapshot. The page link may show a newer release later.	USD 7.71 million Exact value Exact value: 7714000 USD 2025-01-01 – 2025-12-31: 7714000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Vaxart, Inc. · 2025-12-31 Vaxart, Inc. (edgar:72444) Operating Cash Flow: 7714000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 7714000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774926008023/vxrt20251231_10k.htm#1626480 Filing: 000143774926008023 The citation records this snapshot. The page link may show a newer release later.	USD 145,000 Exact value Exact value: 145000 USD 2025-01-01 – 2025-12-31: 145000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Vaxart, Inc. · 2025-12-31 Vaxart, Inc. (edgar:72444) Capital Expenditure: 145000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 145000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774926008023/vxrt20251231_10k.htm#1630478 Filing: 000143774926008023 The citation records this snapshot. The page link may show a newer release later.	USD 7.57 million Calculation and evidence 7714000 − 145000 USD Exact free cash flow: 7569000 USD 2025-01-01 – 2025-12-31: 7714000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 145000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Vaxart, Inc. · 2025-12-31 Vaxart, Inc. (edgar:72444) Free cash flow: 7569000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:53:53Z Snapshot: 754c0611d67456c9810c404d08c94deb4a6c9e2b6774543d14bd6791338dc730 Dimensions: Consolidated View: https://fundies.io/companies/edgar/72444?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 7714000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774926008023/vxrt20251231_10k.htm#1626480 Filing: 000143774926008023 Input fundies:CapitalExpenditure: 145000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/72444/000143774926008023/vxrt20251231_10k.htm#1630478 Filing: 000143774926008023 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

186 filings · 5,219 latest values · 5,219 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000072444, 72444, VXRT, avir, bota, edgar:72444, vxrt

Also known as Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI /DE/, NABI BIOPHARMACEUTICALS, NORTH AMERICAN BIOLOGICALS INC, Vaxart, Inc.

Vaxart, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation